Nov 14, 2011
Company news

TOPTICA sells TILL Photonics to FEI

TILL attracts interest of global player to support future growth into correlative microscopy

TILL Photonics of Munich, Germany, a provider of sophisticated, high resolution, digital light microscopes and high speed imaging systems for live cell microscopy becomes a subsidiary of FEI Inc. (NASDAQ: FEIC), a leading instrumentation company providing imaging and analysis systems for research and industry. With this acquisition, FEI acquires key technology for correlative microscopy in cellular biology, which will integrate high performance light and electron microscopy. TILL Photonics on the other side, will be able to accelerate its growth path into the global life science market within the new framework.

Founded by Prof. Rainer Uhl of Munich University in 1993, TILL has a long and proud tradition as an independent and innovative microscopy company. In 2009, TOPTICA Photonics became major shareholder together with Dr. Frank Lison and Prof. Rainer Uhl and focused the company on innovative technologies like the spinning disc scanner "Andromeda" or the fully automated microscopy platform "more", growing the turn-over to approximately $8 million for calendar year 2011.

"While TILL was looking for interesting OEM opportunities, the initiative of FEI offered us a significant financial return which will strengthen our own future growth", states Dr. Thomas Weber, Vorstand of TOPTICA Photonics AG.

“The very open and flexible microscopes of TILL are an ideal platform for further development into correlative microscopy”, commented Dr. Frank Lison, President of TILL Photonics GmbH. “They will open up new market opportunities for our high-resolution technologies. The strength of FEI will help us to achieve our goals much faster.” Customers can look forward to the same great support they have received from the entire TILL channel as well as the enhanced support of the combined entity. In North America, TILL customers will continue to enjoy the great support of TOPTICA’s US subsidiary, TOPTICA Photonics, Inc.

About TILL
TILL Photonics GmbH develops and markets cutting-edge microscopes and microscopy related products for imaging of living cells since 1993. The flexible imaging platforms enable innovative set-ups that are used in fundamental research, applied science and diagnostics. Its 40 employees are located in Munich, Germany. More information is available at www.till-photonics.com.

About TOPTICA
The laser manufacturer TOPTICA Photonics AG develops and markets diode and fiber laser systems for scientific and industrial applications as used in fundamental research, biophotonics, non-destructive testing and THz inspection. Based in Munich, Germany and Rochester, NY, TOPTICA with its currently 120 employees is one of Europe’s leading photonics companies. More information is available at www.toptica.com.

About FEI
FEI (Nasdaq: FEIC) is a leading diversified scientific instruments company. It is a premier provider of electron- and ion-beam microscopes and solutions for nanoscale applications across many industries: industrial and academic materials research, life sciences, semiconductors, data storage, natural
resources and more. With more than 60 years of technological innovation and leadership, FEI has set the performance standard in transmission electron microscopes (TEM), scanning electron microscopes (SEM) and Dual-Beams™, which combine a SEM with a focused ion beam (FIB). Headquartered
in Hillsboro, Ore., USA, FEI has over 2,000 employees and sales and service operations in more than 50 countries around the world. More information can be found at: www.fei.com.

(FEI Safe Harbor Statement: This news release contains forward-looking statements that include statements regarding the potential benefits and expectations for the acquisition by FEI of TILL Photonics, including its 2011 revenue, as well as FEI’s plans to double its served available market in the next three years. Factors that could affect these forward-looking statements include but are not limited to failure of the TILL product and technology to perform as expected and achieve anticipated results; slower-than-expected development of the correlative microscopy market; failure to successfully integrate TILL’s products and strategy with FEI’s; failure of the company’s plans to expand its markets, including Life Sciences, as expected; a significant cyclical downturn in the company’s existing markets; and the failure of planned new products to expand markets as expected. Please also refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statements.)